Enhanced Cluster Detection Methods for Outbreak Control
(CLUSTER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to enhance hospitals' ability to detect and control disease outbreaks. It tests a new automatic tool, Enhanced Cluster Detection, which uses statistics to identify outbreaks faster than regular methods. The goal is to determine if this tool can help contain outbreaks more quickly, reducing their size and duration. Hospitals within the HCA Healthcare system that provide inpatient care and report data regularly can join the trial. As an unphased trial, this study offers a unique opportunity to advance public health safety and outbreak management.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this method is safe for outbreak control?
Research has shown that automated tools for detecting infection clusters in hospitals hold promise. Studies have found that these systems can identify groups of germs early, which is crucial for controlling infections. Although these tools did not always reduce the size of outbreaks, they provided valuable insights into how outbreaks spread.
This method is not a drug or medical procedure but a tool that helps hospitals identify infection patterns faster than manual methods. Since it is not used directly on people, it does not carry the same safety concerns as treatments or medications. It focuses on enhancing the hospital's ability to respond to outbreaks quickly and effectively.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of enhanced cluster detection methods to improve outbreak control in hospitals. Unlike routine cluster detection practices, this approach uses an automated statistical tool to identify clusters more quickly and accurately. This could lead to faster response times and more effective containment of outbreaks, ultimately improving patient safety and hospital efficiency. By integrating advanced technology into traditional practices, this trial aims to revolutionize how hospitals detect and respond to potential outbreaks.
What evidence suggests that this trial's methods could be effective for outbreak control?
Research has shown that improved methods for identifying case clusters can significantly enhance outbreak detection in hospitals. This trial will compare two approaches: Enhanced cluster detection, which uses an automated statistical cluster detection tool alongside routine practices, and Routine cluster detection, which relies solely on standard practices. A study developed a tool combining statistics and microbiology data, which showed promise in identifying hospital outbreaks faster than older methods. Experiences with detecting clusters in HIV outbreaks demonstrated that automated systems can lead to quicker responses and better control of disease spread. This method uses computer programs to connect cases during an outbreak, helping to identify patterns and clusters early. By detecting outbreaks more quickly, hospitals can respond faster, potentially reducing the size and duration of outbreaks.26789
Who Is on the Research Team?
Richard Platt, MD, MSc
Principal Investigator
Harvard Pilgrim Health Care Institute
Susan Huang, MD, MPH
Principal Investigator
University of California, Irvine
Meghan Baker, MD, ScD
Principal Investigator
Brigham and Women's Hospital
Are You a Good Fit for This Trial?
The CLUSTER Trial is for U.S. HCA Healthcare hospitals providing inpatient care and reporting to a centralized data warehouse during the study period. It's not specified which facilities can't participate, suggesting all eligible ones can join.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cluster Detection and Response
Hospitals implement either enhanced or routine cluster detection methods with a structured response protocol
Follow-up
Participants are monitored for outcomes such as cluster size and duration
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced cluster detection
- Routine cluster detection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Harvard Pilgrim Health Care
Lead Sponsor
Hospital Corporation of America
Industry Sponsor
Centers for Disease Control and Prevention
Collaborator
Harvard School of Public Health (HSPH)
Collaborator
Hospital Corporation of America (HCA) Healthcare
Collaborator
University of Massachusetts, Amherst
Collaborator
Cook County Health & Hospitals System
Collaborator
Duke University
Collaborator
Rush University
Collaborator
University of California, San Francisco
Collaborator